AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Drug Repositioning

Showing 31 to 40 of 256 articles

Clear Filters

Approved drugs successfully repurposed against based on machine learning predictions.

Frontiers in cellular and infection microbiology
Drug repurposing is a promising approach towards the discovery of novel treatments against Neglected Tropical Diseases, such as Leishmaniases, presenting the advantage of reducing both costs and duration of the drug discovery process. In previous wor...

A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs.

International journal of molecular sciences
Repurposing utilizes existing drugs with known safety profiles and discovers new uses by combining experimental and computational approaches. The integration of computational methods has greatly advanced drug repurposing, offering a rational approach...

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy.

BMC biology
BACKGROUND: Drug-target interaction (DTI) prediction plays a pivotal role in drug discovery and drug repositioning, enabling the identification of potential drug candidates. However, most previous approaches often do not fully utilize the complementa...

FuseLinker: Leveraging LLM's pre-trained text embeddings and domain knowledge to enhance GNN-based link prediction on biomedical knowledge graphs.

Journal of biomedical informatics
OBJECTIVE: To develop the FuseLinker, a novel link prediction framework for biomedical knowledge graphs (BKGs), which fully exploits the graph's structural, textual and domain knowledge information. We evaluated the utility of FuseLinker in the graph...

Deep multiple instance learning on heterogeneous graph for drug-disease association prediction.

Computers in biology and medicine
Drug repositioning offers promising prospects for accelerating drug discovery by identifying potential drug-disease associations (DDAs) for existing drugs and diseases. Previous methods have generated meta-path-augmented node or graph embeddings for ...

Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder.

Addiction (Abingdon, England)
BACKGROUND AND AIMS: Amphetamine-type stimulants are the second-most used illicit drugs globally, yet there are no US Food and Drug Administration (FDA)-approved treatments for amphetamine-type stimulant use disorders (ATSUD). The aim of this study w...

AI-Driven Drug Discovery for Rare Diseases.

Journal of chemical information and modeling
Rare diseases (RDs), affecting 300 million people globally, present a daunting public health challenge characterized by complexity, limited treatment options, and diagnostic hurdles. Despite legislative efforts, such as the 1983 US Orphan Drug Act, m...

Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Endometriosis affects over 190 million women globally, and effective therapies are urgently needed to address the burden of endometriosis on women's health. Using an artificial intelligence (AI)-driven target discovery platform, two unreported therap...

Drugs from drugs: New chemical insights into a mature concept.

Drug discovery today
Developing new drugs from marketed ones is a well-established and successful approach in drug discovery. We offer a unified view of this field, focusing on the new chemical aspects of the involved approaches: (a) chemical transformation of the origin...

Biologically Enhanced Machine Learning Model to uncover Novel Gene-Drug Targets for Alzheimer's Disease.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
Given the complexity and multifactorial nature of Alzheimer's disease, investigating potential drug-gene targets is imperative for developing effective therapies and advancing our understanding of the underlying mechanisms driving the disease. We pre...